Brind.

Boston Scientific and Abbott Laboratories Acquire Guidant Amid Industry Restructuring

Steady: 0 in the last 7 days Updated oct 12

The latest in this situation

  1. The FDA approved a new device manufactured by Cordis, a company with a complex history of corporate acquisitions.

How it started

2 reports, 2 independent, last reported Aug 29. The briefing below covers this first event.

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Guidant was acquired by both Boston Scientific and Abbott Laboratories. Separately, CORDIS underwent a transformation from being a division of Cardinal Health. The appointment of Shar Matin as Chief Executive Officer of Cirtec Medical was also announced.

From GlobeNewswire

Why it matters

Some supportBrind's analysis of the reports

The acquisitions of Guidant by Boston Scientific and Abbott Laboratories intensify competition between the two companies in the medical devices market. These corporate moves reflect significant strategic shifts within the healthcare technology sector.

From GlobeNewswire

Who's involved

  • CORDISWas a division of Cardinal Health before its transformation.
  • Cardinal HealthThe parent company of CORDIS.
  • GuidantMedical manufacturing company that was acquired by Boston Scientific and Abbott Laboratories.
  • Boston ScientificAcquired Guidant and is a direct competitor to Abbott Laboratories.
  • Abbott LaboratoriesAcquired Guidant and is a direct competitor to Boston Scientific.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Boston ScientificSpeculative

    Boston Scientific might see changes in market share and product demand due to increased competition with Abbott Laboratories.

  • Abbott LaboratoriesSpeculative

    Abbott Laboratories might see changes in market share and product demand due to increased competition with Boston Scientific.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

How it developed

Newest first. Tap a step to see who reported it.
  1. The FDA approved a new device manufactured by Cordis, a company with a complex history of corporate acquisitions.Sub-event
  2. Alere, now part of Abbott Diagnostics, was previously associated with Cepheid.Sub-event
  3. Boston Scientific acquired Bolt Medical, where Brian Cook worked.Sub-event
  4. CORDIS transformed from Cardinal Health; Guidant acquired by Boston Scientific and Abbott Laboratories; Shar Matin appointed CEO of Cirtec Medical.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireCirtec Medical Announces Appointment of New Chief Executive Officer BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimal
  • StockStoryCAH Q2 Deep Dive: Specialty Expansion and Tariff Headwinds Shape Outlook Healthcare distributor and services company Cardinal Health (NYSE:CAH) fell short of the market’s revenue expectations in Q2 C